Below numbers are from Market Index...but doesn't include all the goodies that NF is helkping himself to since the last GM when they changed the goal posts re options/mile stones.
I've lost touch with what he gets out of the upcoming freebies but recall being disgusted at the time he and the rest of the board put their hands out changing the performance milestones and the general cry out on this board.
There are far more informed posters here that keep better records than me so I leave it to them to tear this down if I'm missing something (actually hope they can tear it down)...I don't think it's correct to say NF hasn't got skin in the game...he has huge skin in the game...now I'll leave it to others to work out what his average purchase price is per share as I think many would like to know that (bulls and bears alike).
I would also point out that this reminds me of the perils that delays caused when our other benefactor failed to exercise their options and the last second poison pill raise that would have worked favourably (or at least as it seemed intended) had scum bag Pattos not put their magic touch to it and driven the SP to 3.8c. Never saw that one coming...but that's my major concern with AVZ...way too much plausible deniability on behalf of management. The Patto's debacle IMO managed to create a poison pill for retailers rather than protecting them from a hostile takeover. It should never have reached that kind of floor. Anyway don't get me started on that one.
This latest guff means that we have no certainty until 30 April and ok no-one saw this virus coming...but if anyone thinks the virus is having an impact on Mr/s Market now give it until May/June and see what happens to the major indices...not a soothsayer but doubt it's going to be pretty unless you're an adept shorter or really good at catching the swings (just IMO).
Anyway lets not get into trade strategy as I only mention it as an aside and everyone has an opinion to which they're welcome. So this is what I"ve managed to find but DYOR as I haven't cross referenced it with the anns and am relying on the source as being accurate:
|
Column 1 |
Column 2 |
Column 3 |
Column 4 |
Column 5 |
Column 6 |
Column 7 |
| 1 |
24/05/17 |
Nigel Ferguson |
Issued |
30,000,000 |
$0.034 |
$1,020,000 |
Issue of securities.
|
|
Column 1 |
Column 2 |
Column 3 |
Column 4 |
Column 5 |
Column 6 |
Column 7 |
| 1 |
29/06/17 |
Nigel Ferguson |
Exercise |
10,000,000 |
$0.034 |
$340,000 |
Conversion of securities. |
|
Column 1 |
Column 2 |
Column 3 |
Column 4 |
Column 5 |
Column 6 |
Column 7 |
| 1 |
29/06/17 |
Nigel Ferguson |
Issued |
10,000,000 |
$0.034 |
$340,000 |
Conversion of securities. |
|
Column 1 |
Column 2 |
Column 3 |
Column 4 |
Column 5 |
Column 6 |
Column 7 |
| 1 |
09/02/18 |
Nigel Ferguson |
Issued |
12,000,000 |
$0.255 |
$3,060,000 |
Issue of securities. |
|
Column 1 |
Column 2 |
Column 3 |
Column 4 |
Column 5 |
Column 6 |
Column 7 |
| 1 |
19/07/18 |
Nigel Ferguson |
Buy |
+20,000,000 |
$0.105 |
$2,100,000 |
Conversion of securities. |
|
Column 1 |
Column 2 |
Column 3 |
Column 4 |
Column 5 |
Column 6 |
Column 7 |
| 1 |
19/07/18 |
Nigel Ferguson |
Exercise |
20,000,000 |
$0.105 |
$2,100,000 |
Conversion of securities. |
|
Column 1 |
Column 2 |
Column 3 |
Column 4 |
Column 5 |
Column 6 |
Column 7 |
| 1 |
01/11/18 |
Nigel Ferguson |
Buy |
+1,000,000 |
$0.065 |
$65,236 |
On-market trade. |
|
Column 1 |
Column 2 |
Column 3 |
Column 4 |
Column 5 |
Column 6 |
Column 7 |
| 1 |
25/02/19 |
Nigel Ferguson |
Buy |
+394,737 |
$0.038 |
$15,000 |
Participation in share purchase plan. |
|
Column 1 |
Column 2 |
Column 3 |
Column 4 |
Column 5 |
Column 6 |
Column 7 |
| 1 |
11/07/19 |
Nigel Ferguson |
Exercise |
3,000,000 |
$0.052 |
$156,000 |
Conversion of securities. |
|
Column 1 |
Column 2 |
Column 3 |
Column 4 |
Column 5 |
Column 6 |
Column 7 |
| 1 |
11/07/19 |
Nigel Ferguson |
Buy |
+3,000,000 |
$0.052 |
$156,000 |
Conversion of securities. |
Wait for any independent verification from others but if I'm reading this correctly looks like NF has around 85 mill shares so far?
Stay safe all.
